Issued Patents All Time
Showing 1–19 of 19 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12291576 | Anti-CD45 antibodies and conjugates thereof | Bradley R. Pearse, Hillary Adams, Sean McDonough, Michael Cooke, Anthony Boitano | 2025-05-06 |
| 12251448 | Compositions and methods for the depletion of CD5+ cells | Anthony Boitano, Michael Cooke, Sean McDonough | 2025-03-18 |
| 12209135 | Anti-CD45 antibodies and conjugates thereof | Anthony Boitano, Michael Cooke, Charlotte McDonagh, Rajiv Panwar, Bradley R. Pearse +2 more | 2025-01-28 |
| 12152080 | Compositions and methods for non-myeloablative conditioning | David T. Scadden, Derrick J. Rossi, Agnieszka Czechowicz | 2024-11-26 |
| 11958908 | Compositions and methods for the depletion of CD117+ cells | Bradley R. Pearse, Michael Cooke, Anthony Boitano, Sean McDonough, Rajiv Panwar +1 more | 2024-04-16 |
| 11572411 | Anti-CD117 antibodies and conjugates | Bradley R. Pearse, Anthony Boitano, Sean McDonough, Rajiv Panwar, Jonathan Belk +1 more | 2023-02-07 |
| 10906980 | Compositions and methods for non-myeloablative conditioning | David T. Scadden, Derrick J. Rossi, Agnieszka Czechowicz | 2021-02-02 |
| 10899843 | Compositions and methods for the depletion of CD117+ cells | Bradley R. Pearse, Michael Cooke, Anthony Boitano, Sean McDonough, Rajiv Panwar +1 more | 2021-01-26 |
| 10882915 | Compositions and methods for the depletion of CD117+ cells | Bradley R. Pearse, Anthony Boitano, Sean McDonough, Rajiv Panwar, Jonathan Belk +1 more | 2021-01-05 |
| 10576161 | Compositions and methods for the depletion of CD137+ cells | Adam Hartigan, Anthony Boitano, Michael Cooke, Megan D. Hoban | 2020-03-03 |
| 10570207 | Compositions and methods for non-myeloablative conditioning | David T. Scadden, Derrick J. Rossi, Agnieszka Czechowicz | 2020-02-25 |
| 10434185 | Compositions and methods for the depletion of CD137+ cells | Adam Hartigan, Anthony Boitano, Michael Cooke, Megan D. Hoban | 2019-10-08 |
| 10285986 | Compounds and anti-tumor NQO1 substrates | Paul J. Hergenrother, David Boothman, Joseph S. Bair, Elizabeth I. Parkinson | 2019-05-14 |
| 10280225 | Compositions and methods for non-myeloablative conditioning | David T. Scadden, Derrick J. Rossi, Agnieszka Czechowicz | 2019-05-07 |
| 9925180 | Compounds and anti-tumor NQO1 substrates | Paul J. Hergenrother, David Boothman, Joseph S. Bair, Elizabeth I. Parkinson | 2018-03-27 |
| 9682060 | Small molecules that induce intrinsic pathway apoptosis | Paul J. Hergenrother, Karson S. Putt | 2017-06-20 |
| 9611266 | Compounds and anti-tumor NQO1 substrates | Paul J. Hergenrother, David Boothman, Joseph S. Bair, Elizabeth I. Parkinson | 2017-04-04 |
| 9233960 | Compounds and anti-tumor NQO1 substrates | Paul J. Hergenrother, David Boothman, Joseph S. Bair, Elizabeth I. Parkinson | 2016-01-12 |
| 7709465 | Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers | Paul J. Hergenrother, Vitaliy Nesterenko, Karson S. Putt | 2010-05-04 |